- Home
- PHAR vs AXGN Comparison
PHAR vs AXGN Comparison
Compare PHAR & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- AXGN
- Stock Information
- Founded
- PHAR 1988
- AXGN N/A
- Country
- PHAR Netherlands
- AXGN United States
- Employees
- PHAR N/A
- AXGN N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PHAR Health Care
- AXGN Health Care
- Exchange
- PHAR Nasdaq
- AXGN Nasdaq
- Market Cap
- PHAR 627.5M
- AXGN 584.7M
- IPO Year
- PHAR N/A
- AXGN N/A
- Fundamental
- Price
- PHAR $8.18
- AXGN $12.64
- Analyst Decision
- PHAR Strong Buy
- AXGN Strong Buy
- Analyst Count
- PHAR 2
- AXGN 4
- Target Price
- PHAR $33.50
- AXGN $15.00
- AVG Volume (30 Days)
- PHAR 6.6K
- AXGN 444.1K
- Earning Date
- PHAR 10-24-2024
- AXGN 11-07-2024
- Dividend Yield
- PHAR N/A
- AXGN N/A
- EPS Growth
- PHAR N/A
- AXGN N/A
- EPS
- PHAR N/A
- AXGN N/A
- Revenue
- PHAR $285,745,000.00
- AXGN $180,855,000.00
- Revenue This Year
- PHAR $20.89
- AXGN $18.91
- Revenue Next Year
- PHAR $11.15
- AXGN $12.93
- P/E Ratio
- PHAR N/A
- AXGN N/A
- Revenue Growth
- PHAR 30.64
- AXGN 18.79
- 52 Week Low
- PHAR $6.65
- AXGN $5.55
- 52 Week High
- PHAR $13.20
- AXGN $15.90
- Technical
- Relative Strength Index (RSI)
- PHAR 47.63
- AXGN 42.96
- Support Level
- PHAR $7.70
- AXGN $12.18
- Resistance Level
- PHAR $8.28
- AXGN $14.17
- Average True Range (ATR)
- PHAR 0.41
- AXGN 1.00
- MACD
- PHAR -0.07
- AXGN -0.19
- Stochastic Oscillator
- PHAR 44.27
- AXGN 25.74
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.